AffaMed Therapeutics

📍 Shanghai, China🗓 Founded 2019👥 47 employees💰 Last funded 2019
Biotechnology🌐 affamed.com
Website LinkedIn
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in AffaMed Therapeutics?
AffaMed Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did AffaMed Therapeutics last raise funding?
The most recent investment in AffaMed Therapeutics recorded on gritt.io was in 2019.
When was AffaMed Therapeutics founded?
AffaMed Therapeutics was founded in 2019.
What industry is AffaMed Therapeutics in?
AffaMed Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is AffaMed Therapeutics based?
AffaMed Therapeutics is headquartered in Shanghai, China.